If you need more lookups,
subscriptions start at $34 USD/month.
Samuel Lee Location
United States
Samuel Lee Work
2019 -now Co-Founder, President, and Chief Business Officer @
2020 -2023 Executive In Residence @
2018 -2020 Director @
2016 -2018 Principal, Life Sciences @
now Angel Investor @
2022 -now Angel Investor @
2021 -now Angel Investor @
now Angel Investor @
2021 -now Angel Investor @
2020 -now Angel Investor @
2019 -now Angel Investor @
now Physician Panelist @
2019 -now Angel Investor @
2017 -now Chair, Board Of Directors @
2018 -now Board Member @
2021 -2022 Angel Investor @
2019 -2022 Board Member @
2018 -2022 Board Observer @
2021 -2021 Angel Investor @
2020 -2021 Angel Investor @
2018 -2021 Board Member @
2017 -2019 Board Observer @ Myoneuxs Therapeutics
2016 -2017 Postdoctoral Research Fellow @
2015 -2017 Physician Panelist @
now Angel Investor @
2013 -2013 MD Intern @
now Board Member @
2012 -2012 Visiting Research Scholar @
now Board Observer @
now Board Member @
2009 -2010 Research Assistant @
2008 -2010 Research Assistant @
now Board Observer @ Myoneuxs Therapeutics
now Postdoctoral Research Fellow @
2004 -2007 Engineering Aide @
Samuel Lee Education
Miami University
Bachelor of Arts (B.A.)
Stanford University Graduate School of Business
Business Administration and Entrepreneurship
The Johns Hopkins University
Masters (Public Health & Health Care Management)
University of Cincinnati
Doctor of Medicine (M.D.)
Samuel Lee Summary
Samuel Lee, based in United States, is currently a Co-Founder, President, and Chief Business Officer at Eikonoklastes Therapeutics, Inc.. Samuel Lee brings experience from previous roles at CincyTech USA and Oculii. Samuel Lee holds a Bachelor of Arts (B.A.) @ Miami University. Samuel Lee has 3 emails and 9 mobile phone numbers on RocketReach.
Looking for a different Samuel Lee?
Find contact details for 700 million professionals.